Join
Live feed
·
INSIDERFilingvia Quantisnow
Five Prime Therapeutics, Inc. logo

SEC Form 4: Civik Thomas disposed of $420,679 worth of Common Stock (11,088 units at $37.94), decreasing direct ownership by 14% to 68,971 units

ByQuantisnow·Wall Street's wire, on your screen.
FPRX· Five Prime Therapeutics, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FPRX (Five Prime Therapeutics, Inc.) and more on Quantisnow.